BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15361869)

  • 1. Early B cell factor cooperates with Runx1 and mediates epigenetic changes associated with mb-1 transcription.
    Maier H; Ostraat R; Gao H; Fields S; Shinton SA; Medina KL; Ikawa T; Murre C; Singh H; Hardy RR; Hagman J
    Nat Immunol; 2004 Oct; 5(10):1069-77. PubMed ID: 15361869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the early B-cell-specific mb-1 (Ig-alpha) gene by Pax-5 is dependent on an unmethylated Ets binding site.
    Maier H; Colbert J; Fitzsimmons D; Clark DR; Hagman J
    Mol Cell Biol; 2003 Mar; 23(6):1946-60. PubMed ID: 12612069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B cell-specific mb-1 promoter.
    Sigvardsson M; Clark DR; Fitzsimmons D; Doyle M; Akerblad P; Breslin T; Bilke S; Li R; Yeamans C; Zhang G; Hagman J
    Mol Cell Biol; 2002 Dec; 22(24):8539-51. PubMed ID: 12446773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A.
    O'Riordan M; Grosschedl R
    Immunity; 1999 Jul; 11(1):21-31. PubMed ID: 10435576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing effects of SWI/SNF and Mi-2/NuRD chromatin remodeling complexes on epigenetic reprogramming by EBF and Pax5.
    Gao H; Lukin K; Ramírez J; Fields S; Lopez D; Hagman J
    Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11258-63. PubMed ID: 19549820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of B-cell differentiation in mice lacking the transcription factor EBF.
    Lin H; Grosschedl R
    Nature; 1995 Jul; 376(6537):263-7. PubMed ID: 7542362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding.
    Roberts EC; Deed RW; Inoue T; Norton JD; Sharrocks AD
    Mol Cell Biol; 2001 Jan; 21(2):524-33. PubMed ID: 11134340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evi3, a zinc-finger protein related to EBFAZ, regulates EBF activity in B-cell leukemia.
    Hentges KE; Weiser KC; Schountz T; Woodward LS; Morse HC; Justice MJ
    Oncogene; 2005 Feb; 24(7):1220-30. PubMed ID: 15580294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements for selective recruitment of Ets proteins and activation of mb-1/Ig-alpha gene transcription by Pax-5 (BSAP).
    Maier H; Ostraat R; Parenti S; Fitzsimmons D; Abraham LJ; Garvie CW; Hagman J
    Nucleic Acids Res; 2003 Oct; 31(19):5483-9. PubMed ID: 14500810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and functional characterization of early B-cell factor, a regulator of lymphocyte-specific gene expression.
    Hagman J; Belanger C; Travis A; Turck CW; Grosschedl R
    Genes Dev; 1993 May; 7(5):760-73. PubMed ID: 8491377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bob1 (OCA-B/OBF-1) differential transactivation of the B cell-specific B29 (Ig beta) and mb-1 (Ig alpha) promoters.
    Malone CS; Wall R
    J Immunol; 2002 Apr; 168(7):3369-75. PubMed ID: 11907094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12.
    Kee BL; Murre C
    J Exp Med; 1998 Aug; 188(4):699-713. PubMed ID: 9705952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human V-preB promoter is a target for coordinated activation by early B cell factor and E47.
    Gisler R; Sigvardsson M
    J Immunol; 2002 May; 168(10):5130-8. PubMed ID: 11994467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early B cell factor is an activator of the B lymphoid kinase promoter in early B cell development.
    Akerblad P; Sigvardsson M
    J Immunol; 1999 Nov; 163(10):5453-61. PubMed ID: 10553071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroblastoma and pre-B lymphoma cells share expression of key transcription factors but display tissue restricted target gene expression.
    Lagergren A; Manetopoulos C; Axelson H; Sigvardsson M
    BMC Cancer; 2004 Nov; 4():80. PubMed ID: 15544702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments.
    Nutt SL; Morrison AM; Dörfler P; Rolink A; Busslinger M
    EMBO J; 1998 Apr; 17(8):2319-33. PubMed ID: 9545244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia.
    Tiacci E; Pileri S; Orleth A; Pacini R; Tabarrini A; Frenguelli F; Liso A; Diverio D; Lo-Coco F; Falini B
    Cancer Res; 2004 Oct; 64(20):7399-404. PubMed ID: 15492262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
    Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
    Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBF-regulating Pax5 transcription is enhanced by STAT5 in the early stage of B cells.
    Hirokawa S; Sato H; Kato I; Kudo A
    Eur J Immunol; 2003 Jul; 33(7):1824-9. PubMed ID: 12811842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A.
    Seet CS; Brumbaugh RL; Kee BL
    J Exp Med; 2004 Jun; 199(12):1689-700. PubMed ID: 15210745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.